Cystic Fibrosis
- HLBS-PopOmics -
What's New
Last Posted: May 17, 2018
- A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?
Alekseyev Yuriy O et al. Academic pathology 52374289518766521 - Cystic Fibrosis Disease Modifiers: Complex Genetics Defines the Phenotypic Diversity in a Monogenic Disease.
O'Neal Wanda K et al. Annual review of genomics and human genetics 2018 Apr - Evaluating the Impact of Precision Medicine: How Ivacaftor Reduces Hospitalizations of Patients with Cystic Fibrosis
RF Green al, CDC Blog Post, May 8, 2018 - Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin Patricia M et al. The Cochrane database of systematic reviews 2018 May 5CD012349 - Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
Feng Lisa B et al. Health affairs (Project Hope) 2018 May 37(5) 773-779 - Precision Medicine In Action: The Impact Of Ivacaftor On Cystic FibrosisRelated Hospitalizations
LB Feng et al, Health Affairs, May 2018 - Disease-modifying genetic factors in cystic fibrosis.
Marson Fernando A L et al. Current opinion in pulmonary medicine 2018 May (3) 296-308 - Delays in adding new newborn screening tests harm babies, families
R Moy et al, STatNews, Apr 30, 2018 - Early diagnosis from newborn screening maximises survival in severe cystic fibrosis.
Tridello Gloria et al. ERJ open research 2018 Apr 4(2) - The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF.
Eckford Paul D W et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2018 Apr
No hay comentarios:
Publicar un comentario